Our portfolio

Nano Hybrids

Nano Hybrids has developed a novel technology that enables the one-step synthesis of a broad range of inorganic/organic core/shell nanoparticles without the use of solvents and additives. This innovative approach enhances efficiency, sustainability, and product purity, making it a significant advancement in nanomaterials. Nano Hybrids is committed to advancing nanotechnology through sustainable and efficient solutions.

Industry: Biotechnology, Chemistry, Nanomaterials

Want to get in contact about Nano Hybrids?

We’re happy to connect. Reach out to our investment manager working with the team to learn more or explore potential opportunities.

Ross Gordon

Chemistry, Biotech & AI

Our portfolio

Check out similar ventures

GuanaRep

Repurposing the obsolete hypertension drug Guanabenz for the treatment of Vanishing White Matter.
Repurposing the obsolete diabetes drug phenformin into an affordable and widely available therapy for pancreatic cancer
Digitizing stroke treatment development and planning with an in-silico stroke simulation platform.
Developing therapeutic antibodies, including the blockbuster RSV drug Nirsevimab.

GuanaRep

Repurposing the obsolete hypertension drug Guanabenz for the treatment of Vanishing White Matter.
Repurposing the obsolete diabetes drug phenformin into an affordable and widely available therapy for pancreatic cancer
Digitizing stroke treatment development and planning with an in-silico stroke simulation platform.
Developing therapeutic antibodies, including the blockbuster RSV drug Nirsevimab.